Bookmark

Add to MyYahoo RSS

Mead Johnson News

News on Mead Johnson (Ticker: MJN) continually updated from thousands of sources around the net.

Thursday Jul 24 | AmericanBankingNews.com

Mead Johnson Nutrition Co PT Raised to $92.00

The firm currently has a "market perform" rating on the stock. BMO Capital Markets' target price would indicate a potential downside of 3.24% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 22, 2014

Seeking Alpha

Mead Johnson Nutrition's (MJN) CEO Kasper Jakobsen on Q2 2014 Results - Earnings Call Transcript

Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition Second Quarter and First Half 2014 Earnings Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Coca-Cola Internation... )--Mad Catz Interactive, Inc. announced today the shipping of the first products in its range of licensed audio headsets for Xbox One under ... )--FUND db x-trackers S&P 500 Shariah UCITS ETF DEALING DATE 21-Jul-14 NAV PER SHARE USD19.7571 NUMBER OF SHARES IN ISSUE 510,000 CODE )--Research and Markets has announced the ... (more)

Comment?

Related Topix: Beverages, CocaCola, Biotech, Medicine, Healthcare Industry

Sat Jul 19, 2014

AmericanBankingNews.com

Mead Johnson Nutrition CO Given Consensus Rating of "Buy" by Analysts

Mead Johnson Nutrition CO has earned a consensus rating of "Buy" from the twelve analysts that are covering the stock, StockRatingsNetwork.com reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Jul 16, 2014

AmericanBankingNews.com

Insider Selling: Mead Johnson Nutrition CO Director Unloads 10,000 Shares of Stock

Mead Johnson Nutrition CO Director Stephen W. Golsby sold 10,000 shares of Mead Johnson Nutrition CO stock in a transaction dated Tuesday, July 15th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 15, 2014

AmericanBankingNews.com

Mead Johnson Nutrition CO Price Target Increased to $97.00 by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co.' s price objective would suggest a potential upside of 4.45% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Banking, JP Morgan Chase

Fri Jul 04, 2014

JD Supra

Expert Witnesses Not Required to Rule Out All Possible Causes in Product Liability Actions

On June 6, 2014, the 8th Circuit Court of Appeals reversed a district court decision excluding three experts, who were critical to the plaintiff to show causation, on the basis that they did not reliably rule out alternative causes of injury.

Comment?

Related Topix: US News, Eighth Circuit Court of Appeals, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••